EODData

PAR, DIM: Sartorius Stedim Biotech SA

29 Sep 2025
LAST:

171.1

CHANGE:
 0.50
OPEN:
172.5
HIGH:
174.1
ASK:
58.9
VOLUME:
71.2K
CHG(%):
0.29
PREV:
171.6
LOW:
170.4
BID:
58.7
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
29 Sep 25172.5174.1170.4171.171.2K
26 Sep 25173.4175.6171.0171.661.8K
25 Sep 25179.5179.7174.4174.551.3K
24 Sep 25186.3186.6180.8181.351.3K
22 Sep 25185.5187.0184.1184.951.7K
19 Sep 25185.1187.2183.7186.0185.2K
18 Sep 25177.3185.0177.3184.874.3K
17 Sep 25175.0178.3173.4177.554.4K
16 Sep 25174.5179.8174.3175.361.3K
15 Sep 25169.5175.6169.5173.941.8K

COMPANY PROFILE

Name:Sartorius Stedim Biotech SA
About:Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. The company has collaboration with Bio Usawa Biotechnology, Ltd. focus on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Sector:Healthcare
Industry:Medical Instruments & Supplies
Address:Zone Industrielle Les Paluds, Aubagne, France, 13781
Website:https://www.sartorius.com
ISIN:FR0013154002
LEI:52990006IVXY7GCSSR39

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:76.20
EPS Ratio:2.30
DivYield:0.00
Div/Share:0.69
Price to Book:4.35
Price to Sales:5.87
EBITDA:695.1M
Shares:97.28M
Market Cap:16.64B

TECHNICAL INDICATORS

MA5:176.65
MA10:178.07
MA20:175.66
MA50:175.94
MA100:186.89
MA200:192.36
STO14:10.06
RSI14:46.02
WPR14:-89.25
MTM14:-4.25
ROC14:-0.02
ATR:5.00
Week High:186.95
Week Low:170.40
Month High:187.15
Month Low:166.10
Year High:239.80
Year Low:148.75

RECENT SPLITS

Date Ratio
06 May 20166-1
16 Jun 20055-1
05 May 199711-10
29 Jan 1996301-292

RECENT DIVIDENDS

Date Amount
02 Apr 2025$0.69
02 Apr 2024$0.69
30 Mar 2023$1.44
31 Mar 2022$1.26
29 Mar 2021$0.68
29 Jun 2020$0.34
29 Mar 2019$0.57
09 Apr 2018$0.46
07 Apr 2017$0.42
13 Apr 2016$0.06